LEADER 00934nam0-22002891i-450- 001 990003160010403321 035 $a000316001 035 $aFED01000316001 035 $a(Aleph)000316001FED01 035 $a000316001 100 $a20000920d1967----km-y0itay50------ba 101 0 $aeng 102 $aIT 200 1 $a<>Politics of International Money and World Language$fCharles P. Kindleberger. 210 $aPrinceton$dN.J.$cInternational Finance Section$dDepartment of Economics$dPrinceton University$d\August \\1967. 215 $a16 p.$d22 cm 225 1 $aEssays in international finance$v61 676 $aO/2.320 702 1$aKindleberger,$bCharles Poor$f<1910-2003> 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003160010403321 952 $aA/71 ESS$b6864 a/I$fSES 959 $aSES 996 $aPolitics of International Money and World Language$9458645 997 $aUNINA DB $aING01 LEADER 01636nam--2200445---450- 001 990000094140203316 005 20090618120451.0 010 $a88-8233-133-4 035 $a0009414 035 $aUSA010009414 035 $a(ALEPH)000009414USA01 035 $a0009414 100 $a20000922d2000----km-y0itay0103----ba 101 0 $aita 102 $aIT 105 $a||||||||001yy 200 1 $aAgriturismo$eturismo rurale, turismo all'aperto$easpetti giuridici, tributari, amministrativi e gestionali. Legislazione, Giurisprudenza. Modulario$econ riferimenti alle diverse leggi regionali e aggiornato con le nuove formalitáa previste dalla Finanziaria 2000 e dal Registro delle Imprese$fGianfranco Ceccacci, Marco V. Susanna 205 $a3 ed. 210 $aMilano$cEdizioni FAG$d2000 215 $a402 p.$d24 cm$e1 CD-rom 606 0 $aTurismo rurale$xLegislazione 676 $a343.4508559104 700 1$aCECCACCI,$bGianfranco$0282846 701 1$aSUSANNA,$bMarco V.$0541569 801 0$aIT$bsalbc$gISBD 912 $a990000094140203316 951 $aXXIV.3.P 215 (IG XVI 306)$b26445 G.$cXXIV.3.P 215 (IG XVI)$d00005870 959 $aBK 969 $aGIU 979 $aTAMI$b40$c20000922$lUSA01$h1009 979 $aTAMI$b40$c20000922$lUSA01$h1306 979 $aTAMI$b40$c20000922$lUSA01$h1330 979 $aTAMI$b40$c20000922$lUSA01$h1337 979 $c20001110$lUSA01$h1710 979 $aPATRY$b90$c20010905$lUSA01$h1228 979 $c20020403$lUSA01$h1617 979 $aPATRY$b90$c20040406$lUSA01$h1607 979 $aRSIAV2$b90$c20090618$lUSA01$h1204 996 $aAgriturismo$9866484 997 $aUNISA LEADER 04033nam 2200481 450 001 9910811321203321 005 20230808192242.0 010 $a0-309-38132-0 010 $a0-309-38130-4 035 $a(CKB)3710000000620228 035 $a(EBL)4455147 035 $a(MiAaPQ)EBC4455147 035 $a(EXLCZ)993710000000620228 100 $a20160505h20162016 uy| 0 101 0 $aeng 135 $aur|n|---||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aAppropriate use of advanced technologies of radiation therapy and surgery in oncology $eworkshop summary /$fSharyl J. Nass and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine 210 1$aWashington, D.C. :$cThe National Academies Press,$d[2016] 210 4$d©2016 215 $a1 online resource (111 p.) 300 $aDescription based upon print version of record. 311 $a0-309-38129-0 327 $aIntroduction -- Overview of new technologies -- Evaluation of comparative effectiveness -- Regulatory oversight -- Rapid widespread adoption of new technologies -- Costs of new technologies -- Value of new technologies -- Potential research challenges -- Study designs -- Training and monitoring clinical performance -- Payment models -- Wrap-up -- References -- Appendix A: Statement of task -- Appendix B: Workshop agenda. 330 $a"In recent years, the field of oncology has witnessed a number of technological advances, including more precise radiation therapy and minimally invasive surgical techniques. Three-dimensional (3D), stereotactic, and proton-beam radiation therapy, as well as laparoscopy and robotic surgery, can enhance clinician's ability to treat conditions that were clinically challenging with conventional technologies, and may improve clinical outcomes or reduce treatment-related problems for some patients. Both patients and physicians seek access to these new technologies, which are rapidly being adopted into standard clinical practice. Such demand is often propelled by marketing that portrays the new technologies as the "latest and greatest" treatments available. However, evidence is often lacking to support these claims, and these novel technologies usually come with higher price tags and are often used to treat patients who might have achieved similar benefits from less expensive, conventional treatment. The increased cost of novel treatments without adequate assessment of how they affect patient outcomes is a pressing concern given that inappropriate use of expensive technologies is one of the key factors that threaten the affordability of cancer care in the United States. To explore these issues further, the National Cancer Policy Forum (NCPF) of the Institute of Medicine organized a workshop in July 2015. This is the third NCPF workshop in a series examining the affordability of cancer care. Participants explored clinical benefits and comparative effectiveness of emerging advanced technologies for cancer treatment in radiation therapy and surgery and potential strategies to assess the value and promote optimal use of new technologies in cancer treatment. This report summarizes the presentations and discussions from the workshop"--$cPublisher description. 606 $aRadiotherapy$xData processing 606 $aOncology 615 0$aRadiotherapy$xData processing. 615 0$aOncology. 676 $a616 700 $aNass$b Sharyl J.$0857626 702 $aPatlak$b Margie 712 02$aInstitute of Medicine.$bBoard on Health Care Services.$bNational Cancer Policy Forum, 712 12$aAppropriate Use of Advanced Technologies for Radiation Therapy and Surgery in Oncology (Workshop)$f(2015 :$eWashington, D.C.) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910811321203321 996 $aAppropriate use of advanced technologies of radiation therapy and surgery in oncology$94019004 997 $aUNINA